MJA
MJA

The management of bipolar disorder in general practice

Philip B Mitchell, Jillian R Ball, James A Best, Bronwyn M Gould, Gin S Malhi, Geoffrey J Riley and Ian G Wilson
Med J Aust 2006; 184 (11): 566-570. || doi: 10.5694/j.1326-5377.2006.tb00382.x
Published online: 5 June 2006
Nature and course of illness

Depression is often the predominant mood and has been associated with the greatest burden of disability. One study found that patients with bipolar I disorder experienced 32% of their weeks of follow-up in depression and 9% in mania or hypomania. For those with bipolar II disorder, 50% of their follow-up period occurred in depression but only 1% in hypomania.4

Suboptimal function between discrete bipolar episodes, characterised by symptoms such as mild anxiety or depression, is common and tends to be unrecognised. The suicide rate in people with bipolar disorder is about 15 times that of the general population, and 80% of suicides occur during episodes of depression. At least 25% of patients will attempt suicide and 10%–20% will complete suicide. Comorbid conditions including anxiety disorders (52% of patients in one Australian study) and substance misuse (39%) are prevalent.1

Role of general practitioners

GPs are well placed to coordinate the care of patients with bipolar disorder as they continue to provide other aspects of general medical care and develop an understanding of the patient’s circumstances and progress.

There is increasing interest in shared care between the primary and secondary care sectors for patients with mental illness.5 It is appropriate for a psychiatrist to assess patients with bipolar disorder early in the illness, to make or confirm the diagnosis and establish a plan for medication and psychological management. Most GPs treat relatively few patients with bipolar disorder, and continuing care for those with severe or frequently recurring illness might best be directed by specialist services. Those with less severe illness, or illness that is responsive to treatment, might best be managed primarily by GPs.

Issues in diagnosis

Patients with bipolar disorder report that delays in diagnosis and incorrect diagnosis are common. A study of participants in a bipolar disorder support group revealed that more than a third sought professional help within a year of the onset of symptoms, but 69% were misdiagnosed, most frequently with unipolar depression.6 Other frequently reported misdiagnoses included anxiety disorder, schizophrenia, borderline or antisocial personality disorder, alcohol or substance misuse and/or dependence, and schizoaffective disorder.6 Over a third waited 10 years or more before receiving an accurate diagnosis. Notably, respondents rarely reported all their manic symptoms to a doctor. For example, fewer than a third admitted symptoms such as reckless behaviour, spending excessively and increased sexual interest or activity.6

The age of the patient influences the differential diagnosis. In younger patients, conditions such as attention deficit hyperactivity disorder and conduct disorder need to be considered. In patients older than 40 years — an age when initial presentation in the manic phase of bipolar disorder is relatively uncommon — possible organic causes should be addressed.

Some “clues” to the presence of bipolar disorder are summarised in Box 1. Note that longitudinal monitoring is often necessary to make or refine the diagnosis.

Management of bipolar disorder
Medication

The main tasks for GPs in managing medication for patients with bipolar disorders are:

Clinical practice guidelines released by the Royal Australian and New Zealand College of Psychiatrists in 2004 provide an authoritative guide to treatment.7 Some principles of treatment for bipolar disorder are listed in Box 2, and recommendations for laboratory monitoring during maintenance therapy are summarised in Box 3. Most research has been conducted in bipolar I disorder and extrapolated to bipolar II disorder when required: there is relatively little direct evidence on medications for bipolar II disorder.

While several guidelines on bipolar disorder have been published internationally, there is considerable unanimity between these. The major distinctions appear to be stronger recommendations for use of lithium in the Australian and European guidelines, with more emphasis on valproate in the United States.8 Furthermore, US guidelines strongly support the use of mood stabilisers alone at an early stage in the treatment of bipolar depression.

The term “mood stabiliser” is used to describe medications that are effective in both acute and maintenance phases of therapy. “Traditional” mood stabilisers are lithium, valproate and carbamazepine, but there is evidence that atypical antipsychotics and the newer anticonvulsants are also effective in at least some phases of bipolar disorder.

Antidepressants in bipolar disorder

The role of antidepressants in bipolar disorder is controversial. A systematic review concluded that antidepressants were effective in the short-term treatment of bipolar depression and that switching to mania was not a common early complication of treatment.9 However, another recent study reported the common occurrence of switching to mania, which was observed in 19% of acute and 37% of long-term antidepressant courses,10 but the study was limited by the lack of a placebo control group.

Patients who stopped taking antidepressants within 6 months of remission from bipolar depression were more likely to relapse within the following year than those who continued treatment.11 This suggests that for many patients continuation of antidepressants beyond the usual 2–3 months recommended in bipolar depression may be preferable.

Relapse and emergency care
Relapse profile

It may be possible to develop a “relapse profile” for individual patients and list how the patient should respond. Common triggers for hypomanic or manic episodes are changes to everyday rhythms (eg, sleeping and eating), and stressful life events.

Possible early warning signs include destructive or impulsive behaviour after being sleepless or irritable, looking haggard, speaking in a caustic manner, telephoning friends indiscriminately regardless of the time, stopping medications, and impulsive, self-destructive threats and gestures.

Strategies to offer the patient when early warning signs of mania occur include the following:

Possible medical and psychological responses to signs of relapse include:

Conclusions

Bipolar disorder is a challenging illness for patients, families and carers, as well as for health care professionals. Increased understanding of the disorder can facilitate early and accurate diagnosis, effective short-term and long-term pharmacological and psychological treatment, and the development of effective support mechanisms.

GPs have a central role in facilitating diagnosis, accessing specialist care, and providing continuing monitoring and support.

Online responses are no longer available. Please refer to our instructions for authors page for more information.